Who Owns CytoMed Therapeutics Limited (GDTC)?Hedge Fund & Institutional Holders
Institutional Holders
2
as of QNaN NaN
Total Institutional Value
$70.3B
% of Float Held
—
QoQ Change in Holders
+2 / -0
Price History
GDTC — Biggest Institutional Buyers This Quarter
| Fund | Shares Added | Value | % of Portfolio |
|---|---|---|---|
| CITADEL ADVISORS LLCNew | 17K | $38.8B | 0.01% |
| UBS Group AGNew | 14K | $31.5B | 0.01% |
Top Institutional Holders(QNaN NaN)
| # | Fund | Shares | Value | % of Portfolio | QoQ Share Change |
|---|---|---|---|---|---|
| 1 | CITADEL ADVISORS LLC | 17,250 | $38.8B | 0.01% | New |
| 2 | UBS Group AG | 14,447 | $31.5B | 0.01% | New |
Similar Stocks by Institutional Ownership
As of QNaN NaN, 2 institutional investors hold GDTC (CytoMed Therapeutics Limited). The largest holder is CITADEL ADVISORS LLC with $38.8B in shares. This quarter, 2 institutions opened new positions and 0 closed their positions.
Frequently Asked Questions
How many hedge funds own GDTC?
As of QNaN NaN, 2 institutional investors report holding GDTC (CytoMed Therapeutics Limited) in their 13F filings.
Who is the largest institutional holder of GDTC?
The largest institutional holder of GDTC is CITADEL ADVISORS LLC with $38.8B in shares.
Is institutional ownership of GDTC increasing or decreasing?
This quarter, 2 institutions opened new positions in GDTC and 0 closed their positions.